(https://doi.org/10.1093/eurheartj/eht273)

The Editors and authors wish to acknowledge that the information presented in Figure 1 about Switzerland has been cast into doubt as it has not been formally published in a data set but communicated verbally by an officer of the WHO to the senior author. Therefore, please also consider the data published by Miserez et al. (Miserez AR, Martin FJ, Spirk D. Diagnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores. Atherosclerosis. 2018 Oct;277:282-288. doi: 10.1016/j.atherosclerosis.2018.08.009.)

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected]